KANPUR PLASTIPACK LTD. Q1 FY27 Results

Delivered PAT growth 93.2% YoY—18% shortfall vs claimed

Pricing advantage offset by ₹3.5 Cr employee cost, lower FIBC volumes, freight headwinds

Delivered revenue ₹203.6 Cr—milestone achieved

Call claimed standalone; OPM 8.1% delivered suggests operating leverage compressed by non-mfg items or consolidated basis

3,000 tons down from 3,500 Q4, 3,800 Q3—trend is downward, not upward

Material contributor; FY25-26 saw ₹10.38 Cr trading profit, ₹7.55 Cr concentrated in Q4—volatile and dependent on market dislocations

Management sold 31% higher per unit vs 18% input cost rise, yet operating margin did not expand due to ₹3.5 Cr labor cost, lower volumes, freight inflation. Operational leverage delayed.

Q3 3,800 tons → Q4 3,500 tons → Q1 3,000 tons. Target is 5,000 tons/quarter by FY28, but current trend is opposite. Management cites supply chain + labor, expects recovery but visibility low.

Non-woven facility (₹40 Cr financing drawn, ₹67-68 Cr total debt by FY27-end) and Essekan JV now live. Diversification thesis operationalized, not theoretical.

GRS (global recycling) and OEKOTEX (chemical toxicity) obtained for Essekan yarn. Management calls these 'extremely strong levers' with brand owners excited. Competitive moat for premium segment.

FY27-28 ₹900-950 Cr; FY28-29 ₹1,000-1,050 Cr (vs ₹203.6 Cr Q1 annualized ~₹815 Cr implied run rate). 3-year CAGR ~40% guided, dependent on Essekan scale and non-woven ramp.

Extreme volatility ±25% in March has stabilized to ±10% now. Government order relaxed on LPG prioritization. Realize increases and decreases are passed to customers with lag (1-4 weeks).

Essekan: 20-25% EBITDA expected this year (₹10 Cr revenue). Non-woven: mid-level double-digit EBITDA. Hard to do first ₹10 Cr, then next 90 easier.

Can reach maximum volume of ₹30 Cr with current capacity. Will expand at 50-60% utilization; capex is low.

EBITDA margin from manufacturing was 12.6% and expanded. But employee cost ₹3 Cr/quarter, FIBC volume decrease due to supply chain, freight up marginally, one-time disruption costs, exhibition participation. Everything together.

FY27-28 target ₹900-950 Cr, FY28-29 ₹1,000-1,050 Cr with installed capacity and current trading. Subject to polymer pricing and trading turnover changes. Better capacity expansion decisions by next year.

High gestation, low capex, high value-add. Sampling now; significant commercialization Q3-Q4. Directional path: ₹10 Cr → ₹25 Cr → ₹50 Cr → ₹100 Cr year-wise. GRS + OEKOTEX certifications are strong levers. Valex has timid revenues, not yet significant tangible benefit.

Already at full operational capacity at 60% mix. Annual savings ₹3-5 Cr. Battery storage discussions ongoing but capex too high right now.

1,200 tons/year addition. Will take 4-5 years to achieve 6,000 tons, constrained by skilled workforce training, not just demand.

Cannot generalize. Macroeconomic view: extreme raw material volatility + market opportunity present. Aim is maximize profit, no fun in sales without profit. But not solely driven by this.

Non-woven: 15-20% IRR, ROCE above 20%. Essekan: far higher ROCE/IRR due to low capex but high brand-building investment.

Total FCI contract ₹15 Cr. ₹25 lakh provision is prudent based on historical shortages/quality complaints on government tenders.

Current long-term debt ₹34 Cr. Will draw ₹40 Cr new term loan for non-woven project. Year-end target ₹67-68 Cr after repayments of ₹5-7 Cr.

We are an outlier. Competitors do not have these certifications.

Completely opportunity driven. Absolutely no company focus. Will take opportunities if they arise but not strategic.

Subject to installed capacity, current trading turnover, and polymer pricing assumptions. Management hedged with caveats.

Long-term aspiration; dependent on Essekan scale, non-woven ramp, and FIBC capacity expansion. 3-year CAGR ~40% from Q1 annualized baseline.

Initial ₹10 Cr guided with confidence, but path to ₹100 Cr (10x) is aspirational, contingent on market acceptance and competitive response.

Vague forward guidance; management unwilling to commit to specific improvement. Near-term margin pressure from labor cost + freight expected for 12-18 months.

Significantly higher than core 8-10%; depends on volume ramp and realization mix. Small base (₹10 Cr) limits impact.

Vague; no specific number. Commissioning Q3 FY27; ramp timeline unclear.

Construction on track for Q3 FY27 commissioning; term loan secured, so capex commitment is real.

Phased expansion; one year elapsed (FY26). Constrained by workforce training, not capex intensity (management claims low capex per ton).

Essekan JV is high gestation (product research, brand approvals, certification). Non-woven facility is first major capex (₹40+ Cr); construction on track but operational ramp uncertain. If either misses 2026-27 targets, revenue growth thesis cracks.

FIBC production fell to 3,000 tons Q1 vs 3,500 Q4, 3,800 Q3. This is the cash cow (52% revenue) and management targets 5,000 tons/quarter by FY28, but current trajectory is downward. Labor disruptions and supply chain fragility cited, but visibility is only 4 weeks.

Ocean freight jumped from $2,000 to $5,000 in last 2 months of Q1. Majority of customers reducing inventory due to high freight and prices. Demand visibility only 4 weeks. While realizations up 31% QoQ, this may not cover freight shock in Q2 if passed through fully.

Employee cost jumped ₹3.5 Cr/quarter due to annual salary revision + state wage policy increase. Management expects offset via cost optimization, automation, productivity over 12-18 months, but this is unproven. If offset takes longer, margin trajectory remains compressed.

Raw material volatility (±25% in March, now ±10%) tied to geopolitical developments. LPG production constraints in March have relaxed but could return. Tariff policies evolving. Supply chain fragility remains. No direct exposure to West Asia/Middle East per management, but indirect via polymer sourcing.